SME
Showing 1–30 of 70 results
-
SME
AccessBio Korea
-
SME
ALTEOGEN Inc.
ALTEOGEN Inc. is a leading bio company whose portfolio includes next-generation biobetters, biosimilars, and proprietary biologics. They are focusing on three cutting-edge areas of the industry – long-acting biobetters, proprietary antibody-drug conjugate (ADC), and antibody biosimilars with high complexity.
-
SME
Bifido
Bifido is a company that focuses on immune therapeutics based on Bifidobacterium. They have been involved in national microbiology projects and have published numerous SCI-grade papers. They have also obtained numerous patents in Korea, the US, and Japan.
-
SME
BioFDNC
-
SME
CELLONTECH
CELLONTECH has focused its R&D efforts on regenerative therapies, aesthetic treatments, blood and immune disorder treatments, in areas such as bone joints, cartilage, bones, connective tissues (ligaments-tendons), and skin.
-
SME
CG Bio
CG Bio Inc. is offering range of innovative solutions for the spectrum of spinal disorders and wound management.
-
SME
DXVX
DXVX is a company that has been involved in various activities. They have launched a probiotic for babies in the global market and have also launched two of their own brand antibiotics in the Chinese antibiotic market, which is the world’s largest. They have also been selected for a national R&D project for technology development for the diagnosis of adult diseases.
-
SME
GENOFOCUS
GenoFocus is a company that develops special enzymes and microbiome therapeutics. They have developed a range of products including industrial special enzymes such as lactase, catalase, and proteinase K.